Stay updated with breaking news from Navin Khattry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Collaborating with a nutraceutical company, Tata Memorial Centre aims to commercialise chromatin-degrading agents, expected for release in June or July. This development holds promise in mitigating treatment-related toxicity, as demonstrated in human trials across various cancers.
Doctors at Tata Memorial Centre have discovered a mechanism for cancer metastasis and developed a nutraceutical therapy to reduce its risk. Their rese
Varanasi: The Homi Bhabha Cancer Hospital, located in Lahartara, has completed successfully 56 bone marrow transplants (BMT) in a span of 18 months.
Noida (Uttar Pradesh) [India], January 4 (ANI/PRNewswire): Curadev Pharma has created a Clinical Advisory Group (CAG) comprising eminent oncologists to provide guidance in the design and execution of immune-oncology clinical trials with CRD3874, its lead non-nucleoside, allosteric small molecule STING agonist
NOIDA, UP, Jan 4: Curadev Pharma has created a Clinical Advisory Group (CAG) comprising eminent oncologists to provide guidance in the design and execution of immune-oncology clinical trials with CRD3874, its lead non-nucleoside, allosteric small molecule STING agonist. Curadev recently received permission from the US FDA to commence FIH trials with systemically administered CRD3874 in patients with advanced/metastatic solid cancers. Dr Arjun Surya, CEO and CSO of Curadev said that, “We are honored to work with such an esteemed group […]